Marker Therapeutics Inc
NASDAQ:MRKR

Watchlist Manager
Marker Therapeutics Inc Logo
Marker Therapeutics Inc
NASDAQ:MRKR
Watchlist
Price: 3.8 USD 1.88% Market Closed
Market Cap: 33.9m USD
Have any thoughts about
Marker Therapeutics Inc?
Write Note

Wall Street
Price Targets

MRKR Price Targets Summary
Marker Therapeutics Inc

Wall Street analysts forecast MRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRKR is 16.07 USD with a low forecast of 12.63 USD and a high forecast of 19.95 USD.

Lowest
Price Target
12.63 USD
232% Upside
Average
Price Target
16.07 USD
323% Upside
Highest
Price Target
19.95 USD
425% Upside
Marker Therapeutics Inc Competitors:
Price Targets
CNTB
Connect Biopharma Holdings Ltd
651% Upside
BBIO
BridgeBio Pharma Inc
91% Upside
ALVO
Alvotech SA
73% Upside
IONS
Ionis Pharmaceuticals Inc
75% Upside
FYB
Formycon AG
80% Upside
MRUS
Merus NV
111% Upside
BCRX
BioCryst Pharmaceuticals Inc
97% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
Marker Therapeutics Inc

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 85%.

N/A
Past Growth
85%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRKR's stock price target?
Price Target
16.07 USD

According to Wall Street analysts, the average 1-year price target for MRKR is 16.07 USD with a low forecast of 12.63 USD and a high forecast of 19.95 USD.

What is Marker Therapeutics Inc's Revenue forecast?
Projected CAGR
85%

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 85%.

Back to Top